tiprankstipranks
Advertisement
Advertisement

JP:4883 Stock Latest News

Modalis Therapeutics Issues Further Corrections to Interim Financial Results
Company AnnouncementsModalis Therapeutics Issues Further Corrections to Interim Financial Results
4d ago
4883
Modalis Revises Interim Results After R&D Expense Timing Error
PremiumCompany Announcements
Modalis Revises Interim Results After R&D Expense Timing Error
4d ago
4883
Modalis Corrects Presentation Errors in Mid-Year Financial Report Without Impacting Results
PremiumCompany Announcements
Modalis Corrects Presentation Errors in Mid-Year Financial Report Without Impacting Results
7d ago
4883
Modalis Books FX Gains and R&D Refund as One-Off Income Boost
PremiumCompany Announcements
Modalis Books FX Gains and R&D Refund as One-Off Income Boost
7d ago
4883
Modalis Issues English Reference Version of Q2 2026 Financial Report
PremiumCompany Announcements
Modalis Issues English Reference Version of Q2 2026 Financial Report
7d ago
4883
Modalis Therapeutics Narrows Interim Loss but Withholds 2026 Outlook
PremiumCompany AnnouncementsModalis Therapeutics Narrows Interim Loss but Withholds 2026 Outlook
7d ago
4883
Modalis Highlights CRISPR-GNDM Platform as Cornerstone of Rare Disease Growth Strategy
Premium
Company Announcements
Modalis Highlights CRISPR-GNDM Platform as Cornerstone of Rare Disease Growth Strategy
1M ago
4883
Modalis Books ¥14 Million in FX Gains, Boosting Quarterly Results
Premium
Company Announcements
Modalis Books ¥14 Million in FX Gains, Boosting Quarterly Results
3M ago
4883
Modalis outlines conditions and limitations around its Q1 2026 disclosure
PremiumCompany Announcements
Modalis outlines conditions and limitations around its Q1 2026 disclosure
3M ago
4883
Modalis Narrows Quarterly Loss but Keeps Outlook Uncertain Amid Zero Revenue
PremiumCompany Announcements
Modalis Narrows Quarterly Loss but Keeps Outlook Uncertain Amid Zero Revenue
3M ago
4883
Modalis Sells Idle U.S. Equipment, Books Extraordinary Gain on Asset Transfer
PremiumCompany Announcements
Modalis Sells Idle U.S. Equipment, Books Extraordinary Gain on Asset Transfer
4M ago
4883
Modalis Sets Terms for 18th Stock Option Plan, Issuing 935,000 Potential Shares
PremiumCompany Announcements
Modalis Sets Terms for 18th Stock Option Plan, Issuing 935,000 Potential Shares
4M ago
4883
Modalis Therapeutics Issues 18th Series Stock Options to Align Incentives and Retain Talent
PremiumCompany AnnouncementsModalis Therapeutics Issues 18th Series Stock Options to Align Incentives and Retain Talent
5M ago
4883
Modalis Outlines FY2025 Growth Plans in Confidential TSE-Mandated Update
Premium
Company Announcements
Modalis Outlines FY2025 Growth Plans in Confidential TSE-Mandated Update
5M ago
4883
Modalis Therapeutics Seeks Approval for Virtual-Ready Shareholder Meetings
Premium
Company Announcements
Modalis Therapeutics Seeks Approval for Virtual-Ready Shareholder Meetings
6M ago
4883
Modalis to Wipe Out Retained Earnings Deficit via Capital Reduction
PremiumCompany Announcements
Modalis to Wipe Out Retained Earnings Deficit via Capital Reduction
6M ago
4883
Modalis Slows IND Timeline for Lead CRISPR Program as It Strengthens Clinical Readiness
PremiumCompany Announcements
Modalis Slows IND Timeline for Lead CRISPR Program as It Strengthens Clinical Readiness
6M ago
4883
Modalis Loss Widens on Higher R&D Spend Amid Zero Revenue in FY2025
PremiumCompany Announcements
Modalis Loss Widens on Higher R&D Spend Amid Zero Revenue in FY2025
6M ago
4883
Modalis Books Foreign Exchange Gain for FY2025 on Currency Revaluation
PremiumCompany Announcements
Modalis Books Foreign Exchange Gain for FY2025 on Currency Revaluation
6M ago
4883
Modalis Issues FY2025 Report With Strict Confidentiality and Risk Disclaimers
PremiumCompany AnnouncementsModalis Issues FY2025 Report With Strict Confidentiality and Risk Disclaimers
6M ago
4883
Modalis posts wider losses in 2025, with no revenue and no 2026 guidance
Premium
Company Announcements
Modalis posts wider losses in 2025, with no revenue and no 2026 guidance
6M ago
4883
Modalis Therapeutics Issues New Shares for Employee Incentive Plan
Premium
Company Announcements
Modalis Therapeutics Issues New Shares for Employee Incentive Plan
9M ago
4883

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >